November 16, 2012—Expectations are growing that a bill may be introduced in Congress soon that would exempt certain generic injectable drugs from 340B drug discounts for possibly up to seven years.
Rep. Bill Cassidy (R-La.), a member of the House Energy and Commerce Subcommittee on Health, has drafted drug shortage legislation that includes the 340B discount exemption and has circulated a letter among his House colleagues seeking co-sponsors.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)
